Skip to main content
Have a personal or library account? Click to login
Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital Cover

Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital

Revista Romana de Medicina de Laborator
Volume 22 (2014): Issue 2 (June 2014)
By: ,  ,  ,  ,   and    
Open Access
|Jun 2014
References

References

  1. 1. Jaenson TGT, Jaenson DGE, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors. 2012;10:5-8. DOI: 10.1186/1756-3305-5-8.
    Open DOISearch in Google Scholar
  2. 2. Berglund J, Eitrem R, Ornstein K. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-27. DOI: 10.1056/ NEJM199511163332004
    Open DOISearch in Google Scholar
  3. 3. Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol. 1999;289(5-7):643-52. DOI: 10.1016/S0934-8840(99)80023-1
    Open DOISearch in Google Scholar
  4. 4. Zöldi V, Juhász A, Nagy C, Papp Z, Egyed L. Tickborne encephalitis and Lyme disease in Hungary: the epidemiological situation between 1998 and 2008. Vector Borne Zoonotic Dis. 2013 Apr;13(4):256-65. DOI: 10.1089/vbz.2011.0905
    Open DOISearch in Google Scholar
  5. 5. Mukhacheva TA, Kovalev SY. Multilocus sequence analysis of Borrelia burgdorferi s.l. in Russia. Ticks Tick Borne Dis. 2013 Jun;4(4):275-9. DOI: 10.1016/j. ttbdis.2013.02.004
    Search in Google Scholar
  6. 6. Coipan EC, Vladimirescu AF. Ixodes ricinus ticks (Acari: Ixodidae): vectors for Lyme disease spirochetes in Romania. Exp Appl Acarol. 2011;54(3):293-300. DOI: 10.1007/s10493-011-9438-4
    Open DOISearch in Google Scholar
  7. 7. Kiss T, Cadar D, Krupaci AF, Bordeanu A, Brudaşcă GF, Mihalca AD, et al. Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania. Vector Borne Zoonotic Dis. 2011;11(9):1259-62. DOI: 10.1089/vbz.2010.0254
    Open DOISearch in Google Scholar
  8. 8. Hristea A, Hristescu S, Ciufecu C, Vasile A. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol. 2001;17(9):891-6. DOI: 10.1023/A:1015600729900
    Open DOISearch in Google Scholar
  9. 9. Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, et al. European Union Concerted Action on Risk Assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr; 1996;108(23):741-7.
    Search in Google Scholar
  10. 10. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2006;43(9):1089-134. DOI: 10.1086/508667
    Open DOISearch in Google Scholar
  11. 11. Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme Borreliosis Serodiagnosis by a Newly Developed Recombinant Immunoglobulin G (IgG) and IgM Line Immunoblot Assay and Addition of VlsE and DbpA Homologues Gereon Goettner. J Clin Microbiol. 2005;43(8):3602-9. DOI: 10.1128/JCM.43.8.3602-3609.2005
    Open DOISearch in Google Scholar
  12. 12. Rosner B. Fundamentals of Biostatistics, 7th Edition. Duxbury Press, 2010.
    Search in Google Scholar
  13. 13. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology. 2004;129 Suppl: S191-220. DOI: 10.1017/S0031182003004694
    Open DOISearch in Google Scholar
  14. 14. Tijsse-Klasen E, Pandak N, Hengeveld P, Takumi K, Koopmans MPG, Sprong H. Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates. Parasit Vectors. 2013;6:23. DOI: 10.1186/1756-3305-6-23
    Open DOISearch in Google Scholar
  15. 15. Svihrova V, Hudeckova H, Jesenak M, Schwarzova K, Kostanova Z, Ciznar I. Lyme borreliosis--analysis of the trends in Slovakia1999-2008. Folia Microbiol. 2011;56(3):270-5. DOI: 10.1007/s12223-011-0036-y
    Open DOISearch in Google Scholar
  16. 16. Bartosik K, Lachowska-Kotowska P, Szymańska J, Pabis A, Buczek A. Lyme borreliosis in south-eastern Poland: relationships with environmental factors and medical attention standards. Ann Agric Environ Med. 2011;18(1):131-7.
    Search in Google Scholar
  17. 17. Van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993 Oct;17(4):708-17. DOI: 10.1093/clinids/17.4.708
    Open DOISearch in Google Scholar
  18. 18. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture- confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130(1):32-6. DOI: 10.7326/0003-4819-130-1-199901050-00006
    Open DOISearch in Google Scholar
  19. 19. Richter D, Klug B, Spielman A, Matuschka FR. Adaptation of Diverse Lyme Disease Spirochetes in a Natural Rodent Reservoir Host. Infect Immun 2004;72(4):2442-4. DOI: 10.1128/IAI.72.4.2442-2444.2004
    Open DOISearch in Google Scholar
  20. 20. Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, et al. Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis. 2011;11(9):1253-8 DOI: 10.1089/vbz.2010.0230
    Open DOISearch in Google Scholar
  21. 21. Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008;22(2):235-60. DOI: 10.1016/j.idc.2007.12.012
    Open DOISearch in Google Scholar
  22. 22. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461-73. DOI: 10.1016/ S0140-6736(11)60103-7
    Search in Google Scholar
  23. 23. Stupica D, Lusa L, Cerar T, Ružić-Sabljić E, Strle F. Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture. Vector Borne Zoonotic Dis. 2011;11(7):883-9. DOI: 10.1089/ vbz.2010.0018
    Open DOISearch in Google Scholar
  24. 24. Glatz M, Golestani M, Kerl H, Müllegger RR. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Arch Dermatol. 2006;142(7):862-8. DOI: 10.1001/archderm.142.7.862
    Open DOISearch in Google Scholar
  25. 25. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al. Ceftriaxone compared with doxycicline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337(5):289-94. DOI: 10.1056/NEJM199707313370501
    Open DOISearch in Google Scholar
  26. 26. Massarotti EM, Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, et al. Treatment of early Lyme disease. Am J Med. 1992;92(4):396-403. DOI: 10.1016/0002-9343(92)90270-L
    Open DOISearch in Google Scholar
  27. 27. Weber K, Wilske B, Preac-Mursic V, Thurmayr R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection. 1993; 21(6):367-372. DOI: 10.1007/BF01728915
    Open DOISearch in Google Scholar
  28. 28. Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D. et al. Longterm follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115(2):91-6. DOI: 10.1016/S0002-9343(03)00308-5
    Open DOISearch in Google Scholar
  29. 29. Wormser, GP, Ramanathan, R, Nowakowski, J, McKenna, D, Holmgren D, Visintainer P, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med.2003;138(9):697-704. DOI: 10.7326/0003-4819-138-9-200305060-00005
    Open DOISearch in Google Scholar
  30. 30. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33(6):780-5. DOI: 10.1086/322669
    Open DOISearch in Google Scholar
  31. 31. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B-cells. Science. 2002;298(5601):2199-202. DOI: 10.1126/science.1076071
    Open DOISearch in Google Scholar
  32. 32. Aguero Rosenfeld ME, Nowakowski J, Bittker S, CooperD, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34(1):1-9.
    Open DOISearch in Google Scholar
  33. 33. Mullegger RR, Glatz M. Is serological follow-up useful for patients with cutaneous Lyme borreliosis? Curr Probl Dermatol. 2009;37:178-82. DOI: 10.1159/000213075
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/rrlm-2014-0021 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Journal RSS Feed
Language: English, Romanian
Page range: 221 - 231
Submitted on: Dec 4, 2013
Accepted on: May 25, 2014
Published on: Jun 21, 2014
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
Lyme disease,
Erythema migrans,
serology,
follow up,
Borreliosis
Related subjects:
Life sciences,
Molecular biology

© 2014 Mihaela Lupșe, Violeta Briciu, Mirela Flonta, Violeta Nastase, Nicolae Todor, Bart-Jan Kullberg, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 22 (2014): Issue 2 (June 2014)
Previous article
Next article